Author: Wang, Xue-Jiao; Zhang, Jun; Wang, Shu-Qing; Xu, Wei-Ren; Cheng, Xian-Chao; Wang, Run-Ling
Title: Identification of novel multitargeted PPARa/?/d pan agonists by core hopping of rosiglitazone Document date: 2014_11_7
ID: uotug8ej_5
Snippet: In our previous research, using GW409544 as the starting point, by means of "core hopping" and "glide docking" techniques, a novel class of PPARα/γ dual agonists was discovered. 14 In this paper, starting from rosiglitazone as the lead compound, using a core hopping approach, the polar head, linker, and hydrophobic tail of rosiglitazone were modified to produce various compounds. These compounds were then screened by docking and absorption, dis.....
Document: In our previous research, using GW409544 as the starting point, by means of "core hopping" and "glide docking" techniques, a novel class of PPARα/γ dual agonists was discovered. 14 In this paper, starting from rosiglitazone as the lead compound, using a core hopping approach, the polar head, linker, and hydrophobic tail of rosiglitazone were modified to produce various compounds. These compounds were then screened by docking and absorption, distribution, metabolism, excretion, and toxicity (ADMET) prediction to discover some excellent PPARα/γ/δ pan agonists. Molecular dynamics simulations of the representative Cpd#1 with PPARα/γ/δ were also done to study the binding details ( Figure 2 ).
Search related documents:
Co phrase search for related documents- lead compound and starting point: 1
- lead compound and toxicity excretion: 1
- lead compound and toxicity excretion metabolism: 1
- lead compound and toxicity excretion metabolism distribution: 1
- lead compound and toxicity excretion metabolism distribution absorption: 1
- linker polar head and polar head: 1, 2
- linker polar head and rosiglitazone hydrophobic tail: 1
- linker polar head and rosiglitazone hydrophobic tail linker polar head: 1
- novel class and starting point: 1
- pan agonist and toxicity excretion: 1
- pan agonist and toxicity excretion metabolism: 1
- pan agonist and toxicity excretion metabolism distribution: 1
- pan agonist and toxicity excretion metabolism distribution absorption: 1
- polar head and rosiglitazone hydrophobic tail: 1
- polar head and rosiglitazone hydrophobic tail linker polar head: 1
- previous research and starting point: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date